Ionscope, a division of Synoptics Ltd based in Cambridge, UK, is a globally recognized leader in Scanning Ion Conductance Microscopy (SICM). Established in 2004 following successful research and development at Imperial College London and the University of Cambridge, Ionscope specializes in nanoscale topographical mapping and precise probe manipulation using innovative Scanning Probe Microscopy (SPM) techniques. In 2019, Ionscope was integrated under the umbrella of Synoptics Ltd, a company with 34 years of digital imaging expertise and multiple divisions including Syngene, Synbiosis, and Synoptics Health. Its technology, including SICM systems, has been deployed in laboratories across Asia, North America, and Europe, facilitating groundbreaking research. In the financial aspect, the last investment in Ionscope was a £680.00K Venture Round investment on 08 August 2007, led by the Cambridge Angels group. This investment indicates external validation and support from an established group in the innovative technology space. As a part of Scientific Digital Imaging plc since 2007, Ionscope brings a wealth of experience in imaging solutions for diverse applications within the manufacturing industry, and its integration within Synoptics Ltd. aligns with a company committed to providing advanced imaging solutions across different sectors.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Venture Round | £680.00K | 1 | Cambridge Angels group | 08 Aug 2007 |
No recent news or press coverage available for Ionscope.